ArticleNeuro-oncology advances

A phase 2 study of abemaciclib in patients with brain metastases secondary to non-small cell lung cancer or melanoma.

Solmaz Sahebjam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.